Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue

Blood (2023) 142 (Supplement 1): 1690.

https://doi.org/10.1182/blood-2023-188245

Published: 2023

Journal Articles

Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

Blood (2023) 142 (Supplement 1): 3471.

https://doi.org/10.1182/blood-2023-178484

Published: 2023

Journal Articles

Circulating Tumor DNA Clearance during Treatment As a Predictive and Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Patients Receiving First-Line Therapy

Yuqin Song, Miaomiao Li, Lan Mi, Chunyang Wang, Xiaojuan Wang, Jianhua Zhu, Fei Qi, Hui Yu, Yingying Ye, Dedao Wang, Jiaowu Cao, Dingyao Hu, Quanyu Yang, Dandan Zhao, Tonghui Ma, Jun Zhu

Blood (2022) 140 (Supplement 1): 3527–3528.

https://doi.org/10.1182/blood-2022-166170

Published: 2022

Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Blood (2022) 140 (Supplement 1): 3189–3191.

https://doi.org/10.1182/blood-2022-165737

Published: 2022

Journal Articles

Analysis of the Tumor Microenvironment By Quantitative Immunohistochemistry Reveals Novel Predictors in Classic Hodgkin Lymphoma Treated with Anti-PD1 Therapy

Hui Yu, Jiali Ni, Zhenchang Sun, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 4530.

https://doi.org/10.1182/blood-2021-152666

Published: 2021

Journal Articles

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

Blood (2021) 138 (Supplement 1): 3830.

https://doi.org/10.1182/blood-2021-147632

Published: 2021

Journal Articles

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Blood (2021) 138 (Supplement 1): 3829.

https://doi.org/10.1182/blood-2021-149999

Published: 2021

Journal Articles

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Lei Zhang, Xiyang Liu, Xinhua Wang, Yu Chang, Xiaorui Fu, Xin Li, Ling Li, Jiaqin Yan, Feifei Nan, Xiaolong Wu, Linan Zhu, Zhenchang Sun, Hui Yu, Mingzhi Zhang

Blood (2021) 138 (Supplement 1): 1368.

https://doi.org/10.1182/blood-2021-152020

Published: 2021

Journal Articles

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-137449

Published: 2020

Journal Articles

Activating NOTCH1 Mutations Alter T-ALL Chemosensitivity By PREX2-AKT Pathway

Hui Yu, MD, PhD, Yuxin DU, MD, M.S., Ji Xu, MD, PhD, Zhenchang Sun, MD, PhD, Xiaorui Fu, MD, PhD, Ken H. Young, MD, PhD, Mingzhi Zhang, MD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-138665

Published: 2020

Journal Articles

Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo

Hui Yu, Geoffrey Neale, Hui Zhang, Han M. Lee, Zhijun Ma, Sheng Zhou, Bernard G. Forget, Brian P. Sorrentino

Blood (2014) 124 (11): 1737–1747.

https://doi.org/10.1182/blood-2013-10-534735

Published: 2014

Includes: Supplemental data

Journal Articles

PTEN Regulated BCRP/ABCG2 and Side Population Through PI3K/Akt Pathway In Chronic Myeloid Leukemia

Fang-Fang Huang, Li Zhang, Yan-Hui Yu, Fang-ping Chen, M.D., Hui Zeng, Ting Niu, MD, PhD, Deng-shu Wu

Blood (2013) 122 (21): 5408.

https://doi.org/10.1182/blood.V122.21.5408.5408

Published: 2013

Journal Articles

An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells

Hongmei Shen, Hui Yu, Paulina H. Liang, Haizi Cheng, Richard XuFeng, Youzhong Yuan, Peng Zhang, Clayton A. Smith, Tao Cheng

Blood (2012) 119 (15): 3629–3637.

https://doi.org/10.1182/blood-2011-08-373621

Published: 2012

Includes: Supplemental data

Journal Articles

Gene Expression Profiling of Murine HOXB4-Transduced HSCs Shows Multiple Counter-Regulatory Signals That May Control HSC Pool Size

Hui Yu, Sheng Zhou, PhD, Geoffrey A. Neale, PhD, Brian P. Sorrentino, MD

Blood (2011) 118 (21): 2361.

https://doi.org/10.1182/blood.V118.21.2361.2361

Published: 2011

Journal Articles

Hematopoietic Stem Cell Repopulation Modulated by ROS-Detoxifying Enzymes,

Richard XuFeng, MD, Moo-Rim Park, MD, Weimin Miao, M.D., Ph.D., Hui Yu, MD, PhD, Michael W. Epperly, Ph.D., Joel S. Greenberger, MD, Tao Cheng, MD

Blood (2011) 118 (21): 4172.

https://doi.org/10.1182/blood.V118.21.4172.4172

Published: 2011

Journal Articles

IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation

Yanping Yang, Hui Wang, Hui Yu, Beow Yong Yeap, Tingting Liang, Guanjun Wang, Tao Cheng, Yong-Guang Yang

Blood (2011) 118 (13): 3721–3724.

https://doi.org/10.1182/blood-2010-05-283887

Published: 2011

Includes: Supplemental data

Journal Articles

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

Joonseok Cho, Hongmei Shen, Hui Yu, Hongjie Li, Tao Cheng, Sean Bong Lee, Byeong Chel Lee

Blood (2011) 117 (4): 1156–1166.

https://doi.org/10.1182/blood-2010-04-279349

Published: 2011

Includes: Supplemental data

Journal Articles

Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells

Jie Jiang, Hui Yu, Yan Shou, Geoffrey Neale, Sheng Zhou, Taihe Lu, Brian P. Sorrentino

Blood (2010) 116 (5): 711–719.

https://doi.org/10.1182/blood-2009-07-235341

Published: 2010

Includes: Supplemental data

Journal Articles

Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation

Hui Yu, Hongmei Shen, Youzhong Yuan, Richard XuFeng, Xiaoxia Hu, Sean P. Garrison, Lin Zhang, Jian Yu, Gerard P. Zambetti, Tao Cheng

Blood (2010) 115 (17): 3472–3480.

https://doi.org/10.1182/blood-2009-10-248278

Published: 2010

Includes: Supplemental data

Journal Articles

Kinetics of normal hematopoietic stem and progenitor cells in a Notch1 -induced leukemia model

Xiaoxia Hu, Hongmei Shen, Chen Tian, Hui Yu, Guoguang Zheng, Richard XuFeng, Zhenyu Ju, Jing Xu, Jianmin Wang, Tao Cheng

Blood (2009) 114 (18): 3783–3792.

https://doi.org/10.1182/blood-2009-06-227843

Published: 2009

Includes: Supplemental data

NARROW

Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

Circulating Tumor DNA Clearance during Treatment As a Predictive and Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Patients Receiving First-Line Therapy

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Analysis of the Tumor Microenvironment By Quantitative Immunohistochemistry Reveals Novel Predictors in Classic Hodgkin Lymphoma Treated with Anti-PD1 Therapy

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Anti-PD-1-Antibody (Tislelizumab) Combined with Deacetylase Inhibitor (Chidamide), Lenalidomide and Etoposide for the Treatment of Refractory/Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single -Arm, Phase II Trial

Fotemustine-Based in Combination with Rituximab As First-Line Induction Chemotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma:a Prospective Phaseii Trial

Activating NOTCH1 Mutations Alter T-ALL Chemosensitivity By PREX2-AKT Pathway

Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo

PTEN Regulated BCRP/ABCG2 and Side Population Through PI3K/Akt Pathway In Chronic Myeloid Leukemia

An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells

Gene Expression Profiling of Murine HOXB4-Transduced HSCs Shows Multiple Counter-Regulatory Signals That May Control HSC Pool Size

Hematopoietic Stem Cell Repopulation Modulated by ROS-Detoxifying Enzymes,

IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells

Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation

Kinetics of normal hematopoietic stem and progenitor cells in a Notch1 -induced leukemia model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only